Skip to content

Integra LifeSciences to Host Fourth Quarter 2009 Earnings Results Conference Call on March 1, 2010


<< Back

Press Release

Jan 19, 2010

Integra LifeSciences to Host Fourth Quarter 2009 Earnings Results Conference Call on March 1, 2010

PLAINSBORO, N.J., Jan. 19, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter and full year 2009 financial results and update its financial guidance for 2010 on Monday, March 1, 2010. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.

Integra’s senior management team will host the conference call, which will be open to all listeners. There will also be a question and answer session following the prepared remarks.

Access to the live call is available by dialing 719-325-2348 and using the passcode 5467929. The call can also be accessed through a webcast via a link provided on the Investor Relations homepage of Integra's website at www.Integra-LS.com. Access to the replay is available through March 15, 2010 by dialing 719-457-0820 and using the passcode 5467929. The webcast will also be archived on the website.

Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Our products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit www.Integra-LS.com

IART-G

CONTACT:  Integra LifeSciences Holdings Corp.
          John B. Henneman III, Executive Vice President,
           Finance and Administration, Chief Financial Officer
            (609) 275-0500
            jhenneman@Integra-LS.com
          Investor Relations
          Angela Steinway
            (609) 936-2268
            angela.steinway@Integra-LS.com

(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.